Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Trigall Genetics is an agricultural biotechnology joint venture focused on developing and commercializing wheat varieties that combine elite germplasm with next-generation biotechnology traits. The company was created by Bioceres and Florimond Desprez and has been positioned as a leader in transgenic wheat, particularly through HB4 drought-tolerance technology and the EcoWheat program. Its activities center on wheat breeding, trait development, and market expansion across Latin America and other major wheat-producing regions. More recently, Bioceres has indicated that Trigall Genetics is focusing on HB4 trait development in wheat while breeding programs are being transferred to Florimond Desprez. The company is not a human healthcare or life sciences therapeutics business; it operates in crop genetics and agricultural biotech.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Trigall Genetics.